The weekly litigation news digest is live. Subscribe now

IP Verse

Dual Inhibitors Of Met And Vegf For The Treatment Of Castration- Resistant Prostate Cancer And Osteoblastic Bone Metastases - EP2621481

The patent EP2621481 was granted to Exelixis on Oct 19, 2022. The application was filed on Sep 26, 2011 under application number EP11764655A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2621481

EXELIXIS
Application Number
EP11764655A
Filing Date
Sep 26, 2011
Status
Patent Maintained As Amended
Sep 16, 2022
Publication Date
Oct 19, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
TEVA PHARMACEUTICALSMay 12, 2020LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20100325095
DESCRIPTIONUS4107288
DESCRIPTIONUS5145684
DESCRIPTIONWO2005030140
DESCRIPTIONWO2008083319
INTERNATIONAL-SEARCH-REPORTWO2005030140
INTERNATIONAL-SEARCH-REPORTWO2009026717
INTERNATIONAL-SEARCH-REPORTWO2009036055
INTERNATIONAL-SEARCH-REPORTWO2009140549
OPPOSITIONUS7579473
OPPOSITIONWO2010083414

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents